Bluejay Diagnostics (BJDX) Stock Statistics & Valuation Metrics

Bluejay Diagnostics has a market cap or net worth of $4.20M. The enterprise value is -$0.85.

Bluejay Diagnostics has 4,468,051 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bluejay Diagnostics’s return on equity (ROE) is -1.15 and return on invested capital (ROIC) is -113.98%.

The current PE Ratio of Bluejay Diagnostics is ―. Bluejay Diagnostics’s PEG ratio is 0.00181.

In the last 12 months, Bluejay Diagnostics had revenue of 0.00 and earned -6.85M in profits. Earnings per share was -15.25.

In the last 12 months, operating cash flow was -5.90M and capital expenditures -335.50K, giving a free cash flow of -6.24M billion.

Bluejay Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

Bluejay Diagnostics upcoming earnings date is Apr 16, 2025, Before Open (Confirmed).

Bluejay Diagnostics as a current ratio of 4.88, with Debt / Equity ratio of 0.86%

In the past 12 months, Bluejay Diagnostics has paid 0.00 in taxes.

Bluejay Diagnostics EV to EBITDA ratio is 0.58, with an EV/FCF ratio of 0.62.

Bluejay Diagnostics has $9.60M in cash and marketable securities with $80.67K in debt, giving a net cash position of $9.52M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Bluejay Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―